These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23233268)
1. Drug-induced macrophage autophagy in atherosclerosis: for better or worse? Martinet W; De Meyer I; Verheye S; Schrijvers DM; Timmermans JP; De Meyer GR Basic Res Cardiol; 2013 Jan; 108(1):321. PubMed ID: 23233268 [TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques. De Meyer I; Martinet W; Schrijvers DM; Timmermans JP; Bult H; De Meyer GR Basic Res Cardiol; 2012 May; 107(3):269. PubMed ID: 22543675 [TBL] [Abstract][Full Text] [Related]
3. Selective clearance of macrophages in atherosclerotic plaques by autophagy. Verheye S; Martinet W; Kockx MM; Knaapen MW; Salu K; Timmermans JP; Ellis JT; Kilpatrick DL; De Meyer GR J Am Coll Cardiol; 2007 Feb; 49(6):706-15. PubMed ID: 17291937 [TBL] [Abstract][Full Text] [Related]
4. mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques. Martinet W; De Loof H; De Meyer GRY Atherosclerosis; 2014 Apr; 233(2):601-607. PubMed ID: 24534455 [TBL] [Abstract][Full Text] [Related]
5. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy. Martinet W; Verheye S; De Meyer GR Autophagy; 2007; 3(3):241-4. PubMed ID: 17224626 [TBL] [Abstract][Full Text] [Related]
6. Everolimus triggers cytokine release by macrophages: rationale for stents eluting everolimus and a glucocorticoid. Martinet W; Verheye S; De Meyer I; Timmermans JP; Schrijvers DM; Van Brussel I; Bult H; De Meyer GR Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1228-35. PubMed ID: 22345170 [TBL] [Abstract][Full Text] [Related]
7. Expression of miRNA-155 in carotid atherosclerotic plaques of apolipoprotein E knockout (ApoE Ma J; Yang S; Ma A; Pan X; Wang H; Li N; Liu S; Wu M Int Immunopharmacol; 2017 May; 46():70-74. PubMed ID: 28273556 [TBL] [Abstract][Full Text] [Related]
8. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Martinet W; De Meyer GR Circ Res; 2009 Feb; 104(3):304-17. PubMed ID: 19213965 [TBL] [Abstract][Full Text] [Related]
9. Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Schrijvers DM; De Meyer GR; Martinet W Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2787-91. PubMed ID: 22096098 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of mTOR by lentivirus‑mediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein E‑deficient mice. Wang X; Li L; Li M; Dang X; Wan L; Wang N; Bi X; Gu C; Qiu S; Niu X; Zhu X; Wang L Int J Mol Med; 2013 Nov; 32(5):1215-21. PubMed ID: 24043133 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of autophagy ameliorates atherogenic inflammation by augmenting apigenin-induced macrophage apoptosis. Wang Q; Zeng P; Liu Y; Wen G; Fu X; Sun X Int Immunopharmacol; 2015 Jul; 27(1):24-31. PubMed ID: 25899084 [TBL] [Abstract][Full Text] [Related]
12. A nano-bioconjugate modified with anti-SIRPα antibodies and antisense oligonucleotides of mTOR for anti-atherosclerosis therapy. Liu Y; Huang Q; He M; Chen T; Chu X Acta Biomater; 2024 Mar; 176():356-366. PubMed ID: 38160854 [TBL] [Abstract][Full Text] [Related]
13. Autophagy in atherosclerosis. Martinet W; De Meyer GR Curr Atheroscler Rep; 2008 Jun; 10(3):216-23. PubMed ID: 18489849 [TBL] [Abstract][Full Text] [Related]
15. Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis. Li W; Sultana N; Siraj N; Ward LJ; Pawlik M; Levy E; Jovinge S; Bengtsson E; Yuan XM J Cell Mol Med; 2016 Sep; 20(9):1664-72. PubMed ID: 27079462 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 7 promotes the apoptosis of THP-1-derived macrophages through the CHOP-dependent pathway. Yu X; Wang Y; Zhao W; Zhou H; Yang W; Guan X Int J Mol Med; 2014 Sep; 34(3):886-93. PubMed ID: 24994112 [TBL] [Abstract][Full Text] [Related]
17. Everolimus depletes plaque macrophages, abolishes intraplaque neovascularization and improves survival in mice with advanced atherosclerosis. Kurdi A; Roth L; Van der Veken B; Van Dam D; De Deyn PP; De Doncker M; Neels H; De Meyer GRY; Martinet W Vascul Pharmacol; 2019 Feb; 113():70-76. PubMed ID: 30590134 [TBL] [Abstract][Full Text] [Related]
18. Low dose tunicamycin enhances atherosclerotic plaque stability by inducing autophagy. Ma M; Song L; Yan H; Liu M; Zhang L; Ma Y; Yuan J; Hu J; Ji Z; Zhang R; Li C; Wang H; Tao L; Zhang Y; Li Y Biochem Pharmacol; 2016 Jan; 100():51-60. PubMed ID: 26616221 [TBL] [Abstract][Full Text] [Related]
19. Macrophage autophagy regulates mitochondria-mediated apoptosis and inhibits necrotic core formation in vulnerable plaques. Xiao Q; Che X; Cai B; Tao Z; Zhang H; Shao Q; Pu J J Cell Mol Med; 2020 Jan; 24(1):260-275. PubMed ID: 31660692 [TBL] [Abstract][Full Text] [Related]
20. Macrophage autophagy plays a protective role in advanced atherosclerosis. Liao X; Sluimer JC; Wang Y; Subramanian M; Brown K; Pattison JS; Robbins J; Martinez J; Tabas I Cell Metab; 2012 Apr; 15(4):545-53. PubMed ID: 22445600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]